SMD360 - Píldoras (in)formativas para Hematólogos | Ana Alfonso Piérola

Ana Alfonso Piérola, from the Clínica Universidad de Navarra, explains why the treatment of high-risk myelodysplastic syndromes remains an unmet medical need. What recommendations do the guidelines establish for patients who are candidates and non-candidates for allogeneic hematopoietic stem cell transplantation?